Beryl Drugs Ltd.

View in App
21.57 +0.42 ▲2.0%

04 October 2023, 04:01:00 PM
Volume: 181

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.beryldrugs.com
Market Cap 10.94 Cr.
Enterprise Value(EV) 14.91 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 2.13 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 10.12 Trailing Twelve Months Ending 2023-06
Industry PE 37.76 Trailing Twelve Months Ending 2023-06
Book Value / Share 16.91 Trailing Twelve Months Ending 2023-06
Price to Book Value 1.28 Calculated using Price: 21.57
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.51 Cr. 5,071,700 Shares
FaceValue 10
About Beryl Drugs Ltd.
Beryl Drugs incorporated in 1993 is into manufacturing and marketing of branded, generic pharmaceutical formulations. The company is one of leading manufacturer of I.V.fluids and small volume injectables.

Beryl Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Beryl Drugs Ltd. Performance

View details >>
1 Day
+1.99%
1 Week
+1.51%
1 Month
-4.43%
3 Month
+33.07%
6 Month
+79.00%
1 Year
+153.17%
2 Year
+29.55%
5 Year
+98.80%
10 Year
-4.56%

Beryl Drugs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.31 2.54 1.74 14.80 8.35 0.63 3.09 -8.68 10.00
Return on Capital Employed (%) 4.92 5.55 4.48 16.88 9.96 4.05 6.28 -3.82 11.51
Return on Assets (%) 0.83 1.62 1.11 9.08 4.67 0.31 1.35 -3.63 4.36

Beryl Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 6 7 7 7 7 8 8 8 7 8
Non Curr. Liab. 0 0 0 0 0 1 3 3 2 3
Curr. Liab. 3 4 3 4 4 6 7 8 9 6
Minority Int.
Equity & Liab. 10 11 10 11 11 14 17 19 18 17
Non Curr. Assets 5 4 4 4 4 9 9 9 7 7
Curr. Assets 5 6 6 7 7 5 8 10 10 10
Misc. Exp. not W/O
Total Assets 10 11 10 11 11 14 17 19 18 17

Beryl Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 13 13 11 15 13 13 14 15 27 30
Other Income 0 0 0 1 0 0 0 0 0
Total Income 14 13 11 16 13 13 14 15 27 30
Total Expenditure -13 -13 -11 -14 -12 -12 -13 -14 -25 -28
PBIDT 1 1 1 2 1 1 2 1 2 3
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 0 0 0 0 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items 0
PAT 0 0 0 1 1 0 0 -1 1 1
Adjusted EPS 0 0 0 2 1 0 0 -1 2 2

Beryl Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 1 0 0 0 3 0 0 0 2
Cash Fr. Inv. 0 0 0 0 0 -5 -2 0 1 -1
Cash Fr. Finan. 0 0 0 0 0 2 2 -1 0 -1
Net Change 0 1 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 1 1 1 0 0 0 0 0 0

Beryl Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 24.92 24.92 24.92 24.92 24.92 24.92 24.92 26.38 26.38
Public 75.08 75.08 75.08 75.08 75.08 75.08 75.08 73.62 73.62
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Beryl Drugs Ltd. Announcements

View details >>
Sat, 30 Sep 2023
Closure of Trading Window
CLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 30TH SEPTEMBER 2023
Fri, 22 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Declaration of results of Remote e-voting and poll voting at the 30th annual general meeting in compliance with the regulation 44(3) of SEBI (LODR) and Scrutinizer report in relation to the 30th annual general meeting held on 21st september 2023
Thu, 21 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
OUTCOME OF 30TH ANNUAL GENERAL MEETING

Beryl Drugs Ltd. Technical Scans

View details >>
Wed, 04 Oct 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month

Beryl Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,145.40 1,121.75 -1.8%
Divi's Laboratories Ltd. 98,393.27 3,702.05 -0.5%
Cipla Ltd. 94,222.95 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. 90,284.76 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. 72,588.97 5,048.70 -1.4%
Mankind Pharma Ltd. 72,396.35 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. 63,113.31 1,865.70 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.91 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 66.52 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 30.29 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.12 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.58 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.53 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.11 1,865.70 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.64 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 7.49 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 3.87 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.68 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.57 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.92 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.60 1,865.70 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,865.70 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,865.70 -0.8%

Beryl Drugs Ltd. FAQ's

What is Beryl Drugs share price?
Can I buy Beryl Drugs shares now?
What is the Market Cap of Beryl Drugs?
What are the key metrics to analyse Beryl Drugs?
What is the 52 Week High and Low of Beryl Drugs?
What is the trend of Beryl Drugs share price?